Q3 2023 · 13F-HR
Knoll Capital Management, LLCholdings as filed
Filed 2023-11-14 · accession 0001104659-23-118123
$96.3M
Reported value
37
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 01438T106 | ALDX | Aldeyra Therapeutics Inc | $20.3M | 21.0% | 3,031,915 | Common | SOLE |
| 03828A101 | APLT | Applied Therapeutics Inc | $12.9M | 13.3% | 5,162,088 | Common | SOLE |
| G11196105 | — | Biohaven Pharmactl Hldg Co L | $12.8M | 13.2% | 490,422 | Common | SOLE |
| 05337M104 | — | Avadel Pharmaceuticals Plc | $6.2M | 6.41% | 600,000 | Common | SOLE |
| 43906K100 | HOOKGBP | HOOKIPA PHARMA | $3.4M | 3.53% | 5,517,385 | Common | SOLE |
| 925050106 | VRNA | Verona Pharma | $3.3M | 3.38% | 200,000 | Common | SOLE |
| 811916105 | SA | SEABRIDGE GOLD INC | $2.6M | 2.70% | 246,597 | Common | SOLE |
| 92189F106 | GDX | Vaneck Gold Miners ETF | $2.5M | 2.57% | 91,850 | Common | SOLE |
| 37954Y848 | SIL | Global X Silver Miners ETF 37954Y848 | $2.1M | 2.23% | 89,700 | Common | SOLE |
| 496902404 | KGC | Kinross Gold Corp | $2.0M | 2.08% | 440,000 | Common | SOLE |
| 351858105 | FNV | Franco Nev Corp CAD | $1.9M | 2.01% | 14,500 | Common | SOLE |
| 962879102 | WPM | Wheaton Precious Metals Corp | $1.9M | 2.00% | 47,500 | Common | SOLE |
| 008474108 | AEM | Agnico Eagle Mines Ltd | $1.8M | 1.89% | 40,000 | Common | SOLE |
| 828363101 | SIL1EUR | Silvercrest Metals Inc CAD | $1.8M | 1.88% | 410,000 | Common | SOLE |
| M40527109 | ENTX | Entera Bio Ltd | $1.8M | 1.87% | 2,484,275 | Common | SOLE |
| 29446Y502 | EQX | Equinox Gold Corp | $1.8M | 1.85% | 420,929 | Common | SOLE |
| 92189F791 | GDXJ | Vaneck Junior Gold Miners ETF | $1.7M | 1.78% | 53,150 | Common | SOLE |
| 55903Q104 | MQ8 | Mag Silver Corp | $1.7M | 1.72% | 160,000 | Common | SOLE |
| 099502106 | BAH | Booz Allen Hamilton HLDG COR | $1.4M | 1.47% | 13,000 | Common | SOLE |
| 32076V103 | AG | First Majestic Silver Corp | $1.4M | 1.46% | 275,000 | Common | SOLE |
| 92826C839 | V | Visa | $1.1M | 1.16% | 4,850 | Common | SOLE |
| 883556102 | TMO | Thermo Fischer Scientific Inc | $1.1M | 1.10% | 2,100 | Common | SOLE |
| 126650100 | CVS | CVS Health Corp | $1.0M | 1.05% | 14,500 | Common | SOLE |
| 02209S103 | MO | Altria Group Inc | $954,535 | 0.99% | 22,700 | Common | SOLE |
| 666807102 | NOC | Northrop Grumman Corp | $953,011 | 0.99% | 2,165 | Common | SOLE |
| 011532108 | AGI | Alamos Gold Inc | $903,200 | 0.94% | 80,000 | Common | SOLE |
| 539830109 | LMT | Lockheed Martin Corp | $879,264 | 0.91% | 2,150 | Common | SOLE |
| 780287108 | RGLD | Royal Gold Inc. | $802,791 | 0.83% | 7,550 | Common | SOLE |
| 697900108 | PAAS | Pan American Silver Corp | $783,150 | 0.81% | 54,085 | Common | SOLE |
| 68827L101 | OREUR | OSISKO GOLD ROYALTIES LTD | $732,000 | 0.76% | 400,000 | Common | SOLE |
| 03237H101 | AMLX | Amylyx | $453,575 | 0.47% | 24,772 | Common | SOLE |
| 68619K105 | — | Orgenesis, Inc. | $393,537 | 0.41% | 634,738 | Common | SOLE |
| 68217N105 | — | Omega Therapeutics Inc. | $371,971 | 0.39% | 173,010 | Common | SOLE |
| 67577R102 | IRD | Ocuphire Pharma Inc. | $335,000 | 0.35% | 100,000 | Common | SOLE |
| 64782A107 | NEWP | New Pac Metals Corp | $233,027 | 0.24% | 131,654 | Common | SOLE |
| 09075P105 | BTAIEUR | BioXcell | $151,800 | 0.16% | 60,000 | Common | SOLE |
| 67576A100 | OCUL | Ocular Therapeutix Inc. | $1,256 | 0.00% | 400 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.